Panelists trace the case of a proposed nano-enabled food-contact textile product to illustrate the FDA regulatory oversight, compliance process, and required interface for approval of the nanomaterial containing product, the scope of proper hazard communication in its manufacture, the unique labeling, warning and product liability implications for the product’s chain of distribution, and comprehensive environmental assessment at end-of-life. Panelists include: